PROPHYLAXIS TREATMENTS Flashcards
Rheumatic Fever: Prevention of Recurrence
Q: What are the two options for preventing recurrence of rheumatic fever?
A: Phenoxymethylpenicillin or sulfadiazine.
Invasive Group A Streptococcal Infection: Prevention of Secondary Cases
Q: What is the recommended prophylactic treatment for preventing secondary cases of invasive group A streptococcal infection?
A: Phenoxymethylpenicillin.
Q: What should be given to penicillin-allergic patients for preventing secondary cases of invasive group A streptococcal infection?
A: Azithromycin, clarithromycin, or erythromycin.
Q: Who should be contacted for advice on who should receive chemoprophylaxis for invasive group A streptococcal infection?
A: The local UKHSA health protection team.
Q: Where can you find further guidance for the management of contacts of invasive group A streptococcus (iGAS) infection in community settings?
A: UKHSA guidance: UK guidelines for the management of contacts of iGAS infection (Useful resources).
Meningococcal Meningitis: Prevention of Secondary Cases
Q: What are the recommended antibiotics for preventing secondary cases of meningococcal meningitis?
A: Ciprofloxacin, rifampicin, or intramuscular ceftriaxone (unlicensed indication).
Q: Who should be consulted to determine who should receive chemoprophylaxis for meningococcal meningitis?
A: A consultant in communicable disease control, infectious diseases, or the local Public Health England laboratory.
Q: Do healthcare workers generally require chemoprophylaxis for meningococcal meningitis? When might they need it?
A: Generally, they do **not **require it. They might need it only if there has been direct exposure to infectious droplets from a patient with meningococcal disease who has received less than 24 hours of antibacterial treatment.
Rheumatic Fever: Prevention of Recurrence
Q: What are the two options for preventing recurrence of rheumatic fever?
A: Phenoxymethylpenicillin or sulfadiazine.
Invasive Group A Streptococcal Infection: Prevention of Secondary Cases
Q: What is the recommended prophylactic treatment for preventing secondary cases of invasive group A streptococcal infection?
A: Phenoxymethylpenicillin.
Q: What should be given to penicillin-allergic patients for preventing secondary cases of invasive group A streptococcal infection?
A: Azithromycin, clarithromycin, or erythromycin.
Q: Who should be contacted for advice on who should receive chemoprophylaxis for invasive group A streptococcal infection?
A: The local UKHSA health protection team.
Q: Where can you find further guidance for the management of contacts of invasive group A streptococcus (iGAS) infection in community settings?
A: UKHSA guidance: UK guidelines for the management of contacts of iGAS infection (Useful resources).
Meningococcal Meningitis: Prevention of Secondary Cases
Q: What are the recommended antibiotics for preventing secondary cases of meningococcal meningitis?
A: Ciprofloxacin, rifampicin, or intramuscular ceftriaxone (unlicensed indication).
Q: Who should be consulted to determine who should receive chemoprophylaxis for meningococcal meningitis?
A: A consultant in communicable disease control, infectious diseases, or the local Public Health England laboratory.
Q: Do healthcare workers generally require chemoprophylaxis for meningococcal meningitis? When might they need it?
A: Generally, they do not require it. They might need it only if there has been direct exposure to infectious droplets from a patient with meningococcal disease who has received less than 24 hours of antibacterial treatment.
Rheumatic Fever: Prevention of Recurrence
What are the two options for preventing recurrence of rheumatic fever?
Rheumatic Fever: Prevention of Recurrence
Q: What are the two options for preventing recurrence of rheumatic fever?
A: Phenoxymethylpenicillin or sulfadiazine.
Invasive Group A Streptococcal Infection: Prevention of Secondary Cases
Q: What is the recommended prophylactic treatment for preventing secondary cases of invasive group A streptococcal infection?
A: Phenoxymethylpenicillin.
Q: What should be given to penicillin-allergic patients for preventing secondary cases of invasive group A streptococcal infection?
A: Azithromycin, clarithromycin, or erythromycin.
Q: Who should be contacted for advice on who should receive chemoprophylaxis for invasive group A streptococcal infection?
A: The local UKHSA health protection team.
Q: Where can you find further guidance for the management of contacts of invasive group A streptococcus (iGAS) infection in community settings?
A: UKHSA guidance: UK guidelines for the management of contacts of iGAS infection (Useful resources).
Meningococcal Meningitis: Prevention of Secondary Cases
Q: What are the recommended antibiotics for preventing secondary cases of meningococcal meningitis?
A: Ciprofloxacin, rifampicin, or intramuscular ceftriaxone (unlicensed indication).
Q: Who should be consulted to determine who should receive chemoprophylaxis for meningococcal meningitis?
A: A consultant in communicable disease control, infectious diseases, or the local Public Health England laboratory.
Q: Do healthcare workers generally require chemoprophylaxis for meningococcal meningitis? When might they need it?
A: Generally, they do not require it. They might need it only if there has been direct exposure to infectious droplets from a patient with meningococcal disease who has received less than 24 hours of antibacterial treatment.
